Sign in

NCT07336693Completed

Bone Density Change in Postmenopausal Rheumatoid Arthritis

Changes in Bone Mineral Density and the Impact of Therapeutic Approaches in Postmenopausal Patients With Rheumatoid Arthritis

Source: ClinicalTrials.gov · Last updated 13 Jan 2026

Brief summary (registry, in English)

Rheumatoid arthritis is associated with systemic inflammation-mediated bone loss, leading to an increased risk of osteoporosis and fractures, particularly in postmenopausal patients. Although disease-modifying antirheumatic drugs may help mitigate bone loss, comparative longitudinal data on different treatment strategies remain limited. This study aimed to evaluate changes in bone mineral density over time and assess the impact of conventional synthetic and biologic DMARDs, together with anti-osteoporotic therapy, on bone health.

Status (registry)
Completed
Study type
Observational
Enrollment
82 (actual)
First submitted
2 Jan 2026
Start date
1 Jun 2025
Primary completion date
1 Sept 2025
Lead sponsor
Istanbul University - Cerrahpasa
NCT number
NCT07336693

What you commit to

  • Study type: Observational
  • Participants enrolled: 82
  • From 1 Jun 2025 to the primary completion date, 1 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Concomitant inflammatory rheumatic diseases other than RA

Other illness

  • History of malignancy
  • Uncontrolled or untreated endocrine or metabolic disorders affecting bone metabolism, such as primary hyperparathyroidism, Cushing's syndrome, severe renal failure, severe hepatic failure

Other

  • Incomplete medical records or missing data

Who the study is looking for

  • Postmenopausal women with a confirmed diagnosis of rheumatoid arthritis

Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istanbul University - Cerrahpasa (IUC)
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.